- Release Date: 04/08/14 13:02
- Summary: GENERAL: CVT: Comvita Supports MPI Interim Guidelines
- Price Sensitive: No
- Download Document 3.35KB
CVT 04/08/2014 13:02 GENERAL REL: 1302 HRS Comvita Limited GENERAL: CVT: Comvita Supports MPI Interim Guidelines Global natural health products company Comvita (NZX: CVT) believes the interim guidelines for Manuka honey which have been released today by MPI, are a step in the right direction to bring much needed discipline to the New Zealand Manuka honey industry. Comvita CEO Brett Hewlett says, "We appreciate the approach that MPI have taken. We will however, reserve judgement on the ability of these interim guidelines to rein in the industry cowboys. Parts of the industry work outside of the recognised UMF(R) standard or use other number systems, which leads to confusion amongst consumers and regulators." "In the absence of good clear industry wide agreed standards and a Government agency like MPI enforcing them, it falls upon well established brands such as Comvita and credible industry players such as those represented by the UMF(R) quality standard, to portray the quality attributes of Manuka honey." "The current benchmark industry standard for Manuka is the Unique Manuka Factor (UMF(R)) quality mark. UMF(R) is a licensed trademark used by over 40 registered New Zealand-based honey producers who have signed up to a voluntary and audited quality standard administered by the UMF Honey Association (UMFHA) of New Zealand. The UMF(R) grading system has been in use for almost 20 years." "Comvita has built a global reputation over 40 years for delivering products of the highest quality to our consumers around the world. We've been exporting Manuka honey to the UK and Asia for over 20 years and have repeatedly proven by independent analysis to be true to label." "We are committed to ongoing discussions with MPI as well as participating in the research needed to further develop the interim guidelines." MPI Q&A: http://www.mpi.govt.nz/food/food-safety/manuka-honey/manuka-honey-questions-a nd-answers # Ends # For further information: Brett Hewlett, Comvita CEO, 021 740 160 Julie Chadwick, Comvita Communications Manager, 021 510 693 Background information About Comvita (www.comvita.com) Comvita (NZX:CVT) is a global natural health company committed to the development of innovative products, backed by ongoing investment in scientific research. We are the world leaders in Manuka (leptospermum) honey and fresh-picked Olive Leaf Extract, which are at the core of the Comvita product range. Comvita pioneered the development and use of medical grade Manuka honey and was the first to receive CE approval (2005) and FDA approval (2007). We partner with US wound care company Derma Sciences Inc., (NASDAQ:DSCI), the global licensee for Medihoney(R) specialist wound care products, which are used in hospitals and medical centres around the world. Comvita processes and sells more than 5,000 tonnes of honey annually, approximately 40% of New Zealand's entire annual harvest. Comvita is also one of New Zealand's largest beekeeping operators, with over 30,000 hives under direct management. Comvita was founded in 1974 and today sells into more than 18 countries through a network of our own branded retail locations, online (nine country specific e-commerce websites) and third-party outlets. We have over 450 staff located in New Zealand, Australia, Hong Kong, Japan, Taiwan, South Korea, the United Kingdom and the USA. End CA:00253453 For:CVT Type:GENERAL Time:2014-08-04 13:02:10
- Forums
- NZX - By Stock
- CVT
- Ann: GENERAL: CVT: Comvita Supports MPI Interim Guidelines
Ann: GENERAL: CVT: Comvita Supports MPI Interim Guidelines
Featured News
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
Add CVT (NZSX) to my watchlist
(20min delay)
|
|||||
Last
$1.15 |
Change
-0.020(1.71%) |
Mkt cap ! n/a |
Open | High | Low | Value | Volume |
$1.17 | $1.18 | $1.15 | $35.17K | 30.38K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
0 | 33151 | $1.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 8952 | 0 |
Last trade - 11.00am 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
CVT (NZSX) Chart |